These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 17028170

  • 1. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.
    Kieda C, Greferath R, Crola da Silva C, Fylaktakidou KC, Lehn JM, Nicolau C.
    Proc Natl Acad Sci U S A; 2006 Oct 17; 103(42):15576-81. PubMed ID: 17028170
    [Abstract] [Full Text] [Related]

  • 2. Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.
    Aprahamian M, Bour G, Akladios CY, Fylaktakidou K, Greferath R, Soler L, Marescaux J, Egly JM, Lehn JM, Nicolau C.
    Chembiochem; 2011 Mar 21; 12(5):777-83. PubMed ID: 21370375
    [Abstract] [Full Text] [Related]

  • 3. myo-Inositol trispyrophosphate: a novel allosteric effector of hemoglobin with high permeation selectivity across the red blood cell plasma membrane.
    Duarte CD, Greferath R, Nicolau C, Lehn JM.
    Chembiochem; 2010 Dec 10; 11(18):2543-8. PubMed ID: 21086482
    [Abstract] [Full Text] [Related]

  • 4. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
    Biolo A, Greferath R, Siwik DA, Qin F, Valsky E, Fylaktakidou KC, Pothukanuri S, Duarte CD, Schwarz RP, Lehn JM, Nicolau C, Colucci WS.
    Proc Natl Acad Sci U S A; 2009 Feb 10; 106(6):1926-9. PubMed ID: 19204295
    [Abstract] [Full Text] [Related]

  • 5. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate.
    Limani P, Linecker M, Kachaylo E, Tschuor C, Kron P, Schlegel A, Ungethuem U, Jang JH, Georgiopoulou S, Nicolau C, Lehn JM, Graf R, Humar B, Clavien PA.
    Clin Cancer Res; 2016 Dec 01; 22(23):5887-5897. PubMed ID: 27489288
    [Abstract] [Full Text] [Related]

  • 6. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy.
    Raykov Z, Grekova SP, Bour G, Lehn JM, Giese NA, Nicolau C, Aprahamian M.
    Int J Cancer; 2014 Jun 01; 134(11):2572-82. PubMed ID: 24214898
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.
    Oknińska M, El-Hafny-Rahbi B, Paterek A, Mackiewicz U, Crola-Da Silva C, Brodaczewska K, Mączewski M, Kieda C.
    J Cell Mol Med; 2020 Feb 01; 24(3):2272-2283. PubMed ID: 31957267
    [Abstract] [Full Text] [Related]

  • 8. Impact of myo-inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models.
    Tran LB, Cao-Pham TT, Jordan BF, Deschoemaeker S, Heyerick A, Gallez B.
    J Cell Mol Med; 2019 Mar 01; 23(3):1908-1916. PubMed ID: 30575283
    [Abstract] [Full Text] [Related]

  • 9. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M, Alsmadi O, Al-Mohanna F.
    Exp Eye Res; 2009 Nov 01; 89(5):700-17. PubMed ID: 19580810
    [Abstract] [Full Text] [Related]

  • 10. Tumour angiogenesis normalized by myo-inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response.
    El Hafny-Rahbi B, Brodaczewska K, Collet G, Majewska A, Klimkiewicz K, Delalande A, Grillon C, Kieda C.
    J Cell Mol Med; 2021 Apr 01; 25(7):3284-3299. PubMed ID: 33624446
    [Abstract] [Full Text] [Related]

  • 11. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC, Lee CF, Huang WH, Chou TC.
    Biochem Pharmacol; 2013 May 01; 85(9):1278-87. PubMed ID: 23416116
    [Abstract] [Full Text] [Related]

  • 12. [Inhibitory effect of siRNA targeting HIF-1alpha on differentiation of peripheral blood endothelial progenitor cells].
    Jiang M, Wang CQ, Wang BY, Huang DJ.
    Ai Zheng; 2005 Nov 01; 24(11):1293-300. PubMed ID: 16552951
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
    Tsuzuki T, Okada H, Cho H, Tsuji S, Nishigaki A, Yasuda K, Kanzaki H.
    Hum Reprod; 2012 Feb 01; 27(2):523-30. PubMed ID: 22128293
    [Abstract] [Full Text] [Related]

  • 14. Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel-like structures in vitro.
    Yuan C, Wang P, Zhu L, Dissanayaka WL, Green DW, Tong EH, Jin L, Zhang C.
    Tissue Eng Part A; 2015 Mar 01; 21(5-6):1163-72. PubMed ID: 25380198
    [Abstract] [Full Text] [Related]

  • 15. Combined endogenous MR biomarkers to assess changes in tumor oxygenation induced by an allosteric effector of hemoglobin.
    Cao-Pham TT, Tran-Ly-Binh A, Heyerick A, Fillée C, Joudiou N, Gallez B, Jordan BF.
    NMR Biomed; 2020 Feb 01; 33(2):e4181. PubMed ID: 31762121
    [Abstract] [Full Text] [Related]

  • 16. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F, Das B.
    Am J Ophthalmol; 2007 Nov 01; 144(5):761-8. PubMed ID: 17869204
    [Abstract] [Full Text] [Related]

  • 17. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
    Sihn G, Walter T, Klein JC, Queguiner I, Iwao H, Nicolau C, Lehn JM, Corvol P, Gasc JM.
    FEBS Lett; 2007 Mar 06; 581(5):962-6. PubMed ID: 17316624
    [Abstract] [Full Text] [Related]

  • 18. Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.
    Kieda C, El Hafny-Rahbi B, Collet G, Lamerant-Fayel N, Grillon C, Guichard A, Dulak J, Jozkowicz A, Kotlinowski J, Fylaktakidou KC, Vidal A, Auzeloux P, Miot-Noirault E, Beloeil JC, Lehn JM, Nicolau C.
    J Mol Med (Berl); 2013 Jul 06; 91(7):883-99. PubMed ID: 23471434
    [Abstract] [Full Text] [Related]

  • 19. Tumour suppressor PTEN activity is differentially inducible by myo-inositol phosphates.
    Grzymajlo K, El Hafny-Rahbi B, Kieda C.
    J Cell Mol Med; 2023 Mar 06; 27(6):879-890. PubMed ID: 36852461
    [Abstract] [Full Text] [Related]

  • 20. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ, Bellamy WT, Briehl MM, Powis G.
    Cancer Res; 2002 Sep 01; 62(17):5089-95. PubMed ID: 12208766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.